Form 8-K - Current report:
SEC Accession No. 0001493152-18-008098
Filing Date
2018-06-01
Accepted
2018-06-01 06:05:14
Documents
2
Period of Report
2018-05-31
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32822
2 ex3-1.htm EX-3.1 137658
  Complete submission text file 0001493152-18-008098.txt   171922
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 18873366
SIC: 7389 Services-Business Services, NEC